Open access
66
Views
1
CrossRef citations to date
0
Altmetric
Original Research
A network biology approach evaluating the anticancer effects of bortezomib identifies SPARC as a therapeutic target in adult T-cell leukemia cells
Junko H Ohyashiki1 Intractable Immune System Disease Research Center, Tokyo Medical University, Tokyo, JapanCorrespondence[email protected]
, Ryoko Hamamura2 First Department of Internal Medicine, Tokyo Medical University, Tokyo, Japan
, Chiaki Kobayashi2 First Department of Internal Medicine, Tokyo Medical University, Tokyo, Japan
, Yu Zhang2 First Department of Internal Medicine, Tokyo Medical University, Tokyo, Japan
& Kazuma Ohyashiki2 First Department of Internal Medicine, Tokyo Medical University, Tokyo, Japan
Pages 85-98
|
Published online: 30 Oct 2008
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.